Kidney injury molecule-1 and osteopontin: New markers for prediction of early kidney transplant rejection

Molecular Immunology

Volumn 54, Issue 3-4, 2013, Pages 457-464

  Jin, Zhan Kui ^a,b   Tian, Pu Xun ^a,b   Wang, Xu Zhen ^a   Xue, Wu Jun ^a,b   Ding, Xiao Ming ^a,b   Zheng, Jin ^a,b   Ding, Cheng Guang ^a   Mao, Tian Ci ^a   Duan, Wan Li ^a   Xi, Min ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute rejection; Biomarker; Kidney injury molecule 1; Kidney transplantation; Osteopontin

Indexed keywords

CYCLOSPORIN A; KIDNEY INJURY MOLECULE 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSTEOPONTIN; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; REJECTION FREE SURVIVAL; SURVIVAL;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GRAFT REJECTION; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; OSTEOPONTIN; PREDICTIVE VALUE OF TESTS; RECEPTORS, VIRUS;

EID: 84874355008     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.01.013     Document Type: Article

References (38)

1. Alchi B., Nishi S., Kondo D., Kaneko Y., Matsuki A., Imai N., Ueno M., Iguchi S., Sakatsume M., Narita I., Yamamoto T., Gejyo F. Osteopontin expression in acute renal allograft rejection. Kidney International 2005, 67:886-896.
2. Ashton-Chess J., Giral M., Soulillou J.P., Brouard S. Using biomarkers of tolerance and rejection to identify high- and low-risk patients following kidney transplantation. Transplantation 2009, 87:S95-S99.
3. Barreto D.V., Lenglet A., Liabeuf S., Kretschmer A., Barreto F.C., Nollet A., Slama M., Choukroun G., Brazier M., Massy Z. Prognostic implication of plasma osteopontin levels in patients with chronic kidney disease. Nephron Clinical Practice 2011, 117:c363-c372.
4. Bonventre J.V. Kidney injury molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scandinavian Journal of Clinical and Laboratory Investigation 2008, 68241:78-83.
5. Bonventre J.V. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrology, Dialysis, Transplantation 2009, 24:3265-3268.
6. Cantor H., Shinohara M.L. Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nature Reviews Immunology 2009, 9:137-141.
7. Chiusolo A., Defazio R., Zanetti E., Mongillo M., Mori N., Cristofori P., Trevisan A. Kidney injury molecule-1 expression in rat proximal tubule after treatment with segment-specific nephrotoxicants: a tool for early screening of potential kidney toxicity. Toxicologic Pathology 2010, 38:338-345.
8. Ding Q., Yeung M., Camirand G., Zeng Q., Akiba H., Yagita H., Chalasani G., Sayegh M.H., Najafian N., Rothstein D.M. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. Journal of Clinical Investigation 2011, 121:3645-3656.
9. Han W.K., Waikar S.S., Johnson A., Betensky R.A., Dent C.L., Devarajan P., Bonventre J.V. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney International 2008, 73:863-869.
10. Hernandez-Fuentes M.P., Lechler R.I. A 'biomarker signature' for tolerance in transplantation. Nature Reviews Nephrology 2010, 6:606-613.
11. Ichimura T., Bonventre J.V., Bailly V., Wei H., Hession C.A., Cate R.L., Sanicola M. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. Journal of Biological Chemistry 1998, 273:4135-4142.
12. Koh A., Batista Da Silva A.P., Bansal A.K., Bansal M., Sun C.X., Lee H.J., Glogauer M., Sodek J., Zohar R. Role of osteopontin in neutrophil function. Immunology 2007, 122:466-475.
13. Lorenzen J.M., Hafer C., Faulhaber-Walter R., Kumpers P., Kielstein J.T., Haller H., Fliser D. Osteopontin predicts survival in critically ill patients with acute kidney injury. Nephrology, Dialysis, Transplantation 2011, 26:531-537.
14. Lorenzen J., Kramer R., Kliem V., Bode-Boeger S.M., Veldink H., Haller H., Fliser D., Kielstein J.T. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. European Journal of Clinical Investigation 2010, 40:294-300.
15. Ma J.A., Usui Y., Takeda K., Harada N., Yagita H., Okumura K., Akiba H. TIM-1 signaling in B cells regulates antibody production. Biochemical and Biophysical Research Communications 2011, 406:223-228.
16. Meyers J.H., Chakravarti S., Schlesinger D., Illes Z., Waldner H., Umetsu S.E., Kenny J., Zheng X.X., Umetsu D.T., DeKruyff R.H., Strom T.B., Kuchroo V.K. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nature Immunology 2005, 6:455-464.
17. Nakae S., Iikura M., Suto H., Akiba H., Umetsu D.T., DeKruyff R.H., Saito H., Galli S.J. TIM-1 and TIM-3 enhancement of Th2 cytokine poduction by mast cells. Blood 2007, 110:2565-2568.
18. Nozaki Y., Nikolic-Paterson D.J., Snelgrove S.L., Akiba H., Yagita H., Holdsworth S.R., Kitching A.R. Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney International 2012, 81:844-855.
19. Order of the State Council No.491. The Regulation on Human Organ Transplantation. http://en.pkulaw.cn/display.aspx%3Fcgid=89844%26lib=law.
20. Peters H., Waanders F., Meijer E., van den Brand J., Steenbergen E.J., van Goor H., Wetzels J. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrology, Dialysis, Transplantation 2011, 26:3581-3588.
21. Renkl A.C., Wussler J., Ahrens T., Thoma K., Kon S., Uede T., Martin S.F., Simon J.C., Weiss J.M. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 2005, 106:946-955.
22. Rennert P.D. Novel roles for TIM-1 in immunity and infection. Immunology Letters 2011, 141:28-35.
23. Rittling S.R. Osteopontin in macrophage function. Expert Reviews in Molecular Medicine 2011, 13:e15.
24. Shinohara M.L., Jansson M., Hwang E.S., Werneck M., Glimcher L.H., Cantor H. T-bet-dependent expression of osteopontin contributes to T cell polarization. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:17101-17106.
25. Shinohara M.L., Kim J.H., Garcia V.A., Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: Role of intracellular osteopontin. Immunity 2008, 29:68-78.
26. Shiomi K., Shiomi S., Ishinaga Y., Sakuraba M., Hagiwara Y., Miyashita K., Maeda M., Suzuki K., Takahashi K., Hino O. Impact of renal failure on the tumor markers of mesothelioma, N-ERC/mesothelin and osteopontin. Anticancer Research 2011, 31:1427-1430.
27. Ueno T., Habicht A., Clarkson M.R., Albin M.J., Yamaura K., Boenisch O., Popoola J., Wang Y., Yagita H., Akiba H., Ansari M.J., Yang J., Turka L.A., Rothstein D.M., Padera R.F., Najafian N., Sayegh M.H. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. Journal of Clinical Investigation 2008, 118:742-751.
28. Umetsu S.E., Lee W.L., McIntire J.J., Downey L., Sanjanwala B., Akbari O., Berry G.J., Nagumo H., Freeman G.J., Umetsu D.T., DeKruyff R.H. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nature Immunology 2005, 6:447-454.
29. Vaidya V.S., Ramirez V., Ichimura T., Bobadilla N.A., Bonventre J.V. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. American Journal of Physiology: Renal Physiology 2006, 290:F517-F529.
30. van Timmeren M.M., Vaidya V.S., van Ree R.M., Oterdoom L.H., de Vries A., Gans R., van Goor H., Stegeman C.A., Bonventre J.V., Bakker S. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007, 84:1625-1630.
31. Wang K.X., Denhardt D.T. Osteopontin: role in immune regulation and stress responses. Cytokine and Growth Factor Reviews 2008, 19:333-345.
32. Xiao L., Fu Z.R., Liu F., Zhang L.D., Shi X.M., Shen X.Y., Ni Z.J., Fu H., Li R.D., Cao X.T., Ding G.S., Wang Q.X. Suppression of allograft rejection by Tim-1-Fc through cross-linking with a novel Tim-1 binding partner on T cells. PLoS ONE 2011, 6:e21697.
33. Xiao S., Zhu B., Jin H.L., Zhu C., Umetsu D.T., DeKruyff R.H., Kuchroo V.K. Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells. European Journal of Immunology 2011, 41:1539-1549.
34. Xie Y.S., Sakatsume M., Nishi S., Narita I., Arakawa M., Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney International 2001, 60:1645-1657.
35. Zhang P.L., Rothblum L.I., Han W.K., Blasick T.M., Potdar S., Bonventre J.V. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney International 2008, 73:608-614.
36. Zhang Z.X., Shek K., Wang S.A., Huang X.Y., Lau A., Yin Z.Q., Sun H.T., Liu W.H., Garcia B., Rittling S., Jevnikar A.M. Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury. Journal of Immunology 2010, 185:967-973.
37. Zhao F., Zhang Y., Wang H., Jin M., He S., Shi Y.F., Guo Y.J., Zhang Y.Y. Blockade of osteopontin reduces alloreactive CD8(+) T cell-mediated graft-versus-host disease. Blood 2011, 117:1723-1733.
38. Zhou Y., Vaidya V.S., Brown R.P., Zhang J., Rosenzweig B.A., Thompson K.L., Miller T.J., Bonventre J.V., Goering P.L. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicological Sciences 2008, 101:159-170.